BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25987036)

  • 1. Establishing a Nomogram for Stage IA-IIB Cervical Cancer Patients after Complete Resection.
    Zhou H; Li X; Zhang Y; Jia Y; Hu T; Yang R; Huang KC; Chen ZL; Wang SS; Tang FX; Zhou J; Chen YL; Wu L; Han XB; Lin ZQ; Lu XM; Xing H; Qu PP; Cai HB; Song XJ; Tian XY; Zhang QH; Shen J; Liu D; Wang ZH; Xu HB; Wang CY; Xi L; Deng DR; Wang H; Lv WG; Shen K; Wang SX; Xie X; Cheng XD; Ma D; Li S
    Asian Pac J Cancer Prev; 2015; 16(9):3773-7. PubMed ID: 25987036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
    Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
    Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative nomogram for prediction of microscopic parametrial infiltration in patients with FIGO stage IB cervical cancer treated with radical hysterectomy.
    Kong TW; Kim J; Son JH; Kang SW; Paek J; Chun M; Chang SJ; Ryu HS
    Gynecol Oncol; 2016 Jul; 142(1):109-114. PubMed ID: 27179979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
    J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of any impact of histopathology type on prognosis in patients with early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Teke F; Yoney A; Teke M; Inal A; Urakci Z; Eren B; Zincircioglu SB; Buyukpolat MY; Ozer A; Isikdogan A; Unsal M
    Asian Pac J Cancer Prev; 2014; 15(6):2815-9. PubMed ID: 24761906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer?
    Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T
    Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathological factors related to the prognosis of chinese patients with stage Ib to IIb cervical cancer.
    Xie XZ; Song K; Cui B; Jiang J; Zhang YZ; Wang B; Yang XS; Kong BH
    Asian Pac J Cancer Prev; 2012; 13(11):5505-10. PubMed ID: 23317208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized prediction of overall survival after postoperative radiation therapy in patients with early-stage cervical cancer: a Korean Radiation Oncology Group study (KROG 13-03).
    Lee HJ; Han S; Kim YS; Nam JH; Kim HJ; Kim JW; Park W; Kim BG; Kim JH; Cha SD; Kim J; Lee KH; Yoon MS; Kim SM; Kim JY; Yoon WS; Lee NW; Choi JH; Park SY; Kim JY
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):659-64. PubMed ID: 24138914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative nomogram predicting risk of recurrence after radical hysterectomy for early-stage cervical cancer.
    Kim MK; Jo H; Kong HJ; Kim HC; Kim JW; Kim YM; Song YS; Kang SB; Mok JE; Lee HP
    Int J Gynecol Cancer; 2010 Dec; 20(9):1581-6. PubMed ID: 21370600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.
    Matsuo K; Shimada M; Nakamura K; Takei Y; Ushijima K; Sumi T; Ohara T; Yahata H; Mikami M; Sugiyama T
    Eur J Surg Oncol; 2019 Aug; 45(8):1417-1424. PubMed ID: 30846298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
    Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
    Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients.
    Tsuruga T; Fujimoto A; Kawana K; Mori M; Hasumi Y; Kino N; Tomio K; Miura S; Tanikawa M; Sone K; Miyamoto Y; Ikeda Y; Kojima S; Adachi K; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Nakagawa S; Horie K; Yasugi T; Yokota H; Osuga Y; Fujii T
    Int J Clin Oncol; 2016 Apr; 21(2):359-366. PubMed ID: 26438230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic-paraaortic lymphadenectomy.
    Metindir J; Bilir G
    Eur J Gynaecol Oncol; 2007; 28(1):28-32. PubMed ID: 17375702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic Risk Factors and Oncologic Outcomes in Early-stage Cervical Cancer Patients Treated by Radical Hysterectomy and Pelvic Lymphadenectomy at a Thai University Hospital: A 7 year Retrospective Review.
    Ruengkhachorn I; Therasakvichya S; Warnnissorn M; Leelaphatanadit C; Sangkarat S; Srisombat J
    Asian Pac J Cancer Prev; 2015; 16(14):5951-6. PubMed ID: 26320478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a nomogram for predicting pelvic lymph node metastasis in cervical squamous cell carcinoma.
    Yang S; Zhao J; Zhao H; Hu Y; Zhu H
    Int J Gynaecol Obstet; 2023 Mar; 160(3):1020-1027. PubMed ID: 36074057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
    Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
    Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
    Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
    Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphadenectomy alone is a feasible option in managing incidentally-detected early-stage cervical cancer after simple hysterectomy without intermediate-risk factors: An application of the concept of less radical surgery.
    Jeon HW; Suh DH; Kim K; No JH; Kim YB
    Anticancer Res; 2013 Nov; 33(11):5135-41. PubMed ID: 24222161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram Predicting Overall Survival in Operable Cervical Cancer Patients.
    Zheng RR; Huang XW; Liu WY; Lin RR; Zheng FY; Lin F
    Int J Gynecol Cancer; 2017 Jun; 27(5):987-993. PubMed ID: 28498238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.